Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.

There is an urgent global need for new strategies and drugs to control and treat multi-drug resistant bacterial infections. In 2017, the World Health Organization (WHO) released a list of 12 antibiotic-resistant priority pathogens and began to critically analyze the antibacterial clinical pipeline....

Full description

Bibliographic Details
Main Authors:	Butler, MS, Gigante, V, Sati, H, Paulin, S, Al-Sulaiman, L, Rex, JH, Fernandes, P, Arias, CA, Paul, M, Thwaites, GE, Czaplewski, L, Alm, RA, Lienhardt, C, Spigelman, M, Silver, LL, Ohmagari, N, Kozlov, R, Harbarth, S, Beyer, P
Format:	Journal article
Language:	English
Published:	American Society for Microbiology 2022

Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.

Similar Items